This article reviews the application of AMPs in oral cancer, esophageal cancer, gastric cancer, liver cancer, pancreatic cancer, and colorectal cancer, and provides a new vision and ideas for the development and clinical application of new drugs for digestive tract tumors. This evidence concerns the gene ADSL and familial pancreatic carcinoma.